ATI-2173 50 mg

DRUG2 trials

Sponsors

Antios Therapeutics, Inc

Conditions

Chronic Hepatitis bDrug Interaction

Phase 1

A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects

CompletedNCT05137548

Antios Therapeutics, IncDrug Interaction

Start: 2021-10-27End: 2021-12-23Updated: 2022-02-04

Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

TerminatedNCT05298332

Antios Therapeutics, IncChronic Hepatitis b

Start: 2022-03-29End: 2022-08-22Updated: 2022-11-18